Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
1 other identifier
observational
99
1 country
1
Brief Summary
The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on an annual basis. We will also determine the type and dose of antipsychotics received. We hypothesize that there has been a significant increase in antipsychotic use, especially atypical antipsychotics, prescribed for patients with PTSD over the last 7 years
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2005
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 29, 2005
CompletedFirst Posted
Study publicly available on registry
October 3, 2005
CompletedSeptember 21, 2006
September 1, 2006
September 29, 2005
September 20, 2006
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Male or female patients, any race or ethnic origin at least 19 years of age.
- Patients with a diagnosis of PTSD
- Treated with an antipsychotic as a monotherapy or adjunctive therapy
- Patient must have been seen at a VA medical center or clinic within VISN 7 during the study period.
You may not qualify if:
- Patients not diagnosed with PTSD
- Not treated with an antipsychotic as a monotherapy or adjunctive therapy
- Patients outside of Network 7
- Patients with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, 35404, United States
Related Publications (1)
Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry. 2005 Jul;66(7):922-7. doi: 10.4088/jcp.v66n0716.
PMID: 16013909BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lori L. Davis, MD
Tuscaloosa Veterans Affairs Medical Center
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 29, 2005
First Posted
October 3, 2005
Study Start
July 1, 2005
Study Completion
September 1, 2005
Last Updated
September 21, 2006
Record last verified: 2006-09